Stocktoria

BAXTER INTERNATIONAL INC BAX

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1961-05-15 · LEI

BAXTER INTERNATIONAL INC financials (annual)

Revenue
$10.16B $10.58B $11.10B $11.36B $11.67B $12.15B $10.06B $10.36B $10.64B $11.24B 2016201720182019202020212022202320242025
Net income
$4.96B $602.0M $1.55B $1.00B $1.10B $1.28B -$2.43B $2.66B -$649.0M -$957.0M 2016201720182019202020212022202320242025
Free cash flow
2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$11.2B$10.6B$10.4B$10.1B$12.1B$11.7B$11.4B$11.1B$10.6B$10.2B
Gross profit$3.4B$4.0B$4.2B$3.5B$4.7B$4.6B$4.8B$4.8B$4.5B$4.1B
R&D expense$518.0M$590.0M$518.0M$450.0M$531.0M$521.0M$595.0M$654.0M$615.0M$646.0M
SG&A expense$2.9B$3.0B$3.0B$3.1B$2.8B$2.5B$2.5B$2.6B$2.6B$2.7B
Operating income-$308.0M$14.0M$707.0M-$2.8B$1.4B$1.6B$1.8B$1.6B$1.3B$745.0M
Interest expense$290.0M$408.0M$508.0M$413.0M$207.0M$153.0M$111.0M$93.0M$85.0M$89.0M
Income tax$395.0M$37.0M$61.0M-$135.0M$83.0M$182.0M-$41.0M$65.0M$491.0M-$12.0M
Net income-$957.0M-$649.0M$2.7B-$2.4B$1.3B$1.1B$1.0B$1.5B$602.0M$5.0B
EPS (diluted)$-1.87$-1.27$5.23$-4.83$2.53$2.13$1.93$2.83$1.08$9.01
Operating cash flow$951.0M$1.0B$1.7B$1.2B$2.2B$1.9B$2.1B$2.0B$1.7B$1.7B
Cash & equivalents$2.0B$1.8B$3.1B$1.6B$3.0B$3.7B$3.3B$1.8B$3.4B$2.8B
Inventory$2.2B$2.0B$1.9B$2.7B$2.5B$1.9B$1.7B$1.7B$1.5B$1.4B
Total assets$20.1B$25.8B$28.3B$28.3B$33.5B$20.0B$18.2B$15.7B$17.1B$15.5B
Total liabilities$14.0B$18.8B$19.8B$22.4B$24.4B$11.3B$10.3B$7.9B$8.0B
Shareholders' equity$6.1B$7.0B$8.5B$5.9B$9.1B$8.7B$7.9B$7.9B$9.1B$8.3B

Growth · year-over-year · Revenue CAGR 1.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+5.7%+2.7%+3.0%-17.2%+4.1%+2.7%+2.4%+4.9%+4.1%+2.0%
Net income growth-124.4%-289.5%+16.5%+10.1%-35.3%+156.8%-87.9%+412.9%
EPS growth-124.3%-290.9%+18.8%+10.4%-31.8%+162.0%-88.0%+411.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.